Zhang J, Luo J, Shen X, Ren J, et al. Timing matters: Impact of covalent BTK inhibitor dose modifications on outcomes in chronic lymphocytic leukemia/small lymphocytic leukemia-A 7-year real-world study. Cancer 2026;132:e70578.
PMID: 42740716